SG Americas Securities’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,786
Closed -$1.63M 3097
2022
Q3
$1.63M Sell
10,786
-9,396
-47% -$1.42M 0.02% 573
2022
Q2
$2.94M Buy
20,182
+8,714
+76% +$1.27M 0.03% 444
2022
Q1
$1.36M Sell
11,468
-8,210
-42% -$974K 0.01% 1060
2021
Q4
$2.71M Sell
19,678
-336
-2% -$46.3K 0.01% 767
2021
Q3
$2.78M Buy
20,014
+10,709
+115% +$1.49M 0.01% 886
2021
Q2
$903K Buy
9,305
+472
+5% +$45.8K ﹤0.01% 1469
2021
Q1
$604K Sell
8,833
-1,823
-17% -$125K ﹤0.01% 1713
2020
Q4
$913K Sell
10,656
-3,327
-24% -$285K ﹤0.01% 1388
2020
Q3
$909K Buy
13,983
+6,252
+81% +$406K 0.01% 1027
2020
Q2
$565K Sell
7,731
-22,097
-74% -$1.61M ﹤0.01% 1688
2020
Q1
$1.02M Buy
29,828
+27,596
+1,236% +$939K 0.01% 1018
2019
Q4
$122K Buy
+2,232
New +$122K ﹤0.01% 2439
2019
Q2
Sell
-11,196
Closed -$576K 3093
2019
Q1
$576K Sell
11,196
-2,501
-18% -$129K 0.01% 1507
2018
Q4
$507K Buy
+13,697
New +$507K ﹤0.01% 1588
2018
Q3
Sell
-4,826
Closed -$191K 3096
2018
Q2
$191K Buy
+4,826
New +$191K ﹤0.01% 2293